Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;34(7):1163-1164.
doi: 10.1038/s41433-020-0905-1. Epub 2020 Apr 29.

Implications of COVID-19 for uveitis patients: perspectives from Hong Kong

Jennifer C H Hung  1 , Kenneth K W Li  2
Affiliations
Comment

Implications of COVID-19 for uveitis patients: perspectives from Hong Kong

Jennifer C H Hung et al. Eye (Lond). 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment on

References

    1. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. doi: 10.1136/bmj.m1198. - DOI - PubMed
    1. Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020. 10.1007/s00417-020-04641-8. - PMC - PubMed
    1. Sim D, Thomas P, Canning T. Tackling COVID-19 with telemedicine [Internet]. The Opthalmologist. https://theophthalmologist.com/subspecialties/tackling-covid-19-with-tel.... Accessed 19 March 2020 [cited 28 March 2020].
    1. Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118:1916–26. doi: 10.1016/j.ophtha.2011.07.027. - DOI - PMC - PubMed
    1. Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, et al. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet’s disease: a multicenter study. Ophthalmology. 2014;121:1877–84. doi: 10.1016/j.ophtha.2014.04.042. - DOI - PubMed